← SynDRA
TESMILIFENE
SynDRA canonical compound SYN0001583 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ABCB1 | HRH1 |
|---|
| Mechanism of action | histamine receptor antagonist |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- LTA4H
- ALOX15B
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- GMNN
- HDAC6
- HTT
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- GEMI
- GLI3
- JUN
- KCNH2
- NR1I2
- NSD2
- NTM1A
- NTMT1
- TSHR
Drug classes
- Histamine Antagonists
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- Tesmilifeno
- DPPE
- DPPE hydrocloride
- Tesmilifene hydrochloride
- BMS 217380-01
- BMS-217380
- BMY-33419
- DPPE, BMS
- YMB-1002
- Anticancer, BMS/Manitoba Univ/MTCR
- dppe
- Depmpe
- tesmilifeno
- (2-(4-benzylphenoxy)ethyl)diethylamine
- I43T3ID6G2
- N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine
- n,n-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine
- DTXCID9025661
- [2-(4-benzylphenoxy)ethyl]diethylamine
- N,N-diethyl-2-(4-(phenylmethyl)phenoxy)ethanamine
- tesmilifenum
- RefChem:188316
- 2-(4-benzylphenoxy)-N,N-diethylethanamine
- Tesmilifene [INN]
- N,N-DIETHYL-2-[4-BENZYLPHENOXY]ETHANAMINE
- Ethanamine, N,N-diethyl-2-(4-(phenylmethyl)phenoxy)-
- NCGC00024762-02
- UNII-I43T3ID6G2
- CAS-98774-23-3
- Ethanamine, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-
- YMB1002
- Tocris-0743
- TESMILIFENE [MI]
- 2-((alpha-Phenyl-p-tolyl)oxy)triethylamine
- TESMILIFENE [WHO-DD]
- SCHEMBL112525
- orb2564413
- CHEBI:93414
- NFIXBCVWIPOYCD-UHFFFAOYSA-N
Look up TESMILIFENE in the interactive SynDRA portal →